Mr. William White joined Brainstorm in September 2020 and serves as Senior Vice President and Head of Market Access and Pricing. He has more than 25 years’ experience in leading successful product commercialization and securing market access for innovative new medicines.

Mr. White was most recently Vice President of Patient Access at Avexis, now Novartis Gene Therapies. While at Avexis, he led a large team responsible for securing coverage and reimbursement and developing patient support services with national and regional insurers and state Medicaid payers. His work in developing and implementing the market access strategy for AVXS-101/Zolgensma® helped to expedite delivery of a novel new treatment to an underserved patient population and helped the company transition to the commercial stage. Mr. White has also held leadership positions in sales, managed care and patient access at Insys Therapeutics and Lundbeck (formerly Ovation Pharmaceuticals).

In addition to his specialization in market access, reimbursement and distribution design and implementation, Mr. White has expertise in rare/orphan diseases, gene therapy, neuromuscular disease, alliance management, value based contracting, and leadership development. He holds a B.S. in Business Administration from Rider University and resides in Scottsdale, AZ.